tiprankstipranks
Lantern Pharma, Inc. (LTRN)
NASDAQ:LTRN
US Market

Lantern Pharma (LTRN) Cash flow

205 Followers

Lantern Pharma Cash Flow

LTRN's free cash flow for Q4 2023 was $-3.39M. For the 2023 fiscal year, LTRN's free cash flow was decreased by $-1.57M and operating cash flow was $-3.39M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -14.35M$ -14.35M$ -12.77M$ -10.59M$ -5.65M$ -2.13M
Investing Cash Flow
$ -930.21K$ -930.21K$ 179.27K$ -19.53M$ -16.14K$ -5.72K
Financing Cash Flow
$ -500.00K$ -500.00K$ -2.18M$ 63.42M$ 23.66M$ 2.92M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 109.49M$ 21.94M$ 37.20M$ 52.52M$ 19.23M$ 1.23M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
---$ 69.00M$ 26.25M$ 2.92M
Issuance Of Debt
----$ 277.55K$ 0.00
Repayment Of Debt
----$ -169.05K$ 0.00
Free Cash Flow
$ -14.37M$ -14.37M$ -12.80M$ -10.61M$ -5.67M$ -2.13M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Lantern Pharma Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis